Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ASTELLAS-PHARMA-INC-6491262/nieuws/Vyloy-van-Astellas-Pharma-Inc-zolbetuximab-goedgekeurd-in-Japan-voor-de-behandeling-van-maagkan-46293899/?utm_source=whatsapp&utm_medium=social&utm_campaign=share